Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis
Condition: Progressive Multiple Sclerosis Interventions: Drug: biotin; Other: propensity score Sponsors: University Hospital, Clermont-Ferrand; OFSEP (Observatoire Français de la Sclérose en Plaques); SFSEP (Société Francophone de la Sclérose en Plaques); MedDay Pharmaceuticals SA Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials